Clinical Trials Logo

Functional Dyspepsia clinical trials

View clinical trials related to Functional Dyspepsia.

Filter by:

NCT ID: NCT06326918 Recruiting - Clinical trials for Functional Dyspepsia

Duodenal Microbiota in Functional Dyspepsia

Start date: February 12, 2024
Phase:
Study type: Observational

The goal of this observational study is to assess the type of duodenal microbiota and duodenal microbiome in in FD patients compared to control group. The main questions it aims to answer are: - What are the differences in the type of duodenal microbiota and is there a difference in duodenal microbiome diversity between patients diagnosed with functional dyspepsia (FD) and the control group? - Are there any significant variations in the composition and diversity of gut microbiota between patients with FD and the control group, considering the method of sample collection (duodenal brushing vs. duodenal biopsy)?

NCT ID: NCT06313814 Enrolling by invitation - Clinical trials for Functional Dyspepsia

The Effect of Ginger on Functional Dyspepsia Symptoms and Body Fat Content Among Patients With Functional Dyspepsia

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to assess ginger's effect on patients with functional dyspepsia. The main question[s] it aims to answer are: 1. Does ginger intake improve functional dyspepsia symptoms? 2. Does ginger intake decrease the body fat content among patients with functional dyspepsia? Dyspepsia patients will be asked to take 540 mg of ginger capsule twice a day. Researchers will assess if there is an improvement in the symptoms of the disease and the fat content. [ to see if gingers effect.

NCT ID: NCT06217393 Not yet recruiting - Clinical trials for Functional Dyspepsia

Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia

Start date: January 15, 2024
Phase: Phase 3
Study type: Interventional

The study is conducted in patients with functional dyspepsia or chronic gastritis. The purpose of this study is to: - assess whether the dose of Itopride Hydrochloride 150 mg extended release tablets, taken once daily has a similar effect on gastrointestinal symptoms caused by gastric dysmotility and delayed gastric emptying, like bloating sensation, early satiety, postprandial fullness, upper abdominal pain or discomfort, anorexia, heartburn, nausea and vomiting in functional (non-ulcer) dyspepsia or chronic gastritis, as Itopride Hydrochloride 50 mg film coated tablets administered thrice a day. - investigate assessment of the treatment provided to each participant. - monitor safety and tolerability of Itopride Hydrochloride 150 mg extended release tablets, taken once daily before one of the main meals (preferably same meal throughout the treatment) and Itopride Hydrochloride 50 mg film coated tablets thrice daily before meals.

NCT ID: NCT06068114 Recruiting - Healthy Clinical Trials

Gastric Pathophysiology in Diabetes

DiaFLIP
Start date: October 5, 2022
Phase:
Study type: Observational [Patient Registry]

This is a comprehensive pathophysiological study assessing various gastric functions in patients with diabetes mellitus. The investigators aim to examine the stomach with various measurement devices to gain information about its different functions and malfunctions. After the initial measurements, the examinations will be repeated after a year in each patient. Changes in the measurement values will be examined and their relations to each other and to the overall health of the patients will be investigated. For example it is hypothesised that diabetic patients also suffering from functional dyspepsia or gastroparesis will also show some changes in the function of the pyloric muscle.

NCT ID: NCT06005805 Completed - Clinical trials for Functional Dyspepsia

A Study To Evaluate the Feasibility of the Decentralized Clinical Trial in South Korea

Start date: August 21, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the feasibility of a decentralized clinical trial in South Korea. The main questions it aims to answer are: - Does decentralized elements feasible in Korea? - Does Mastic gum alleviates symptoms and modifies stool microbiome in Korean patients with functional dyspepsia?

NCT ID: NCT05920395 Not yet recruiting - Clinical trials for Functional Dyspepsia

Mechanisms of Electroacupuncture for Functional Dyspepsia Based on "Enterotypes" and Metabolomics

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to explore the clinical efficacy and possible mechanisms of electroacupuncture treatment for functional dyspepsia (FD). The main question it aims to answer are: - Differences in the effects of electroacupuncture and sham electroacupuncture intervention on FD. - Differences in gastrointestinal hormone levels and gut microbiota and their metabolites between healthy individuals and FD patients. Participants receive electroacupuncture and sham electroacupuncture interventions respectively. Before and after the intervention, the clinical symptom score, gastrointestinal symptom evaluation scale, gastrointestinal symptom score questionnaire, and functional dyspepsia quality of life scale of the subjects will be observed. The levels of gastrointestinal hormones MTL, Ghrelin, 5-HT, CCK, PYY, and GLP-1 will be measured, as well as the changes in microbial diversity and SCFAs in their metabolites in feces, A follow-up visit will be conducted one month after the intervention for all participants.

NCT ID: NCT05915520 Recruiting - Clinical trials for Functional Dyspepsia

Baduanjin Program Effect on Geriatric Functional Dyspepsia

Start date: July 20, 2023
Phase: N/A
Study type: Interventional

functional dyspepsia is very common between geriatric population

NCT ID: NCT05842408 Not yet recruiting - Clinical trials for Functional Dyspepsia

Phase III Clinical Trial of DA-5212 in Patients With Functional Dyspepsia

Start date: May 2023
Phase: Phase 3
Study type: Interventional

This study is to evaluate efficacy and safety of DA-5212 in patients with functional dyspepsia

NCT ID: NCT05836597 Not yet recruiting - Clinical trials for Functional Dyspepsia

Functional Dyspepsia Treatment Using Virtual Reality

Start date: March 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.

NCT ID: NCT05827575 Recruiting - Clinical trials for Functional Dyspepsia

Transcutaneous Auricular Vagal Nerve Stimulation for Functional Dyspepsia With Sleep Disturbances: a Randomized Controlled Trial

Start date: March 30, 2022
Phase: N/A
Study type: Interventional

Functional dyspepsia(FD) is most common in functional gastrointestinal disorders whose rick factors include sleep disturbances. The medication treatment for functional dyspepsia with sleep disturbances has disadvantages such as addiction and withdrawal symptoms. Transcutaneous auricular vagal nerve stimulation(taVNS) is a new therapeutic method to improve dyspepsia and sleep. Study on taSNS for FD with sleep disturbances has not yet been explored.